ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.99
0.42%
US Tech 100
20,389.60
0.88%
S&P 500
6,032.38
0.56%
US Dollar vs CAD
1.40155
0.00%
Bitcoin
96,963.58
0.55%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Onconova Therapeutics Inc (ONTX)

  7. Onconova Therapeutics Inc (ONTX) News

ONTX

Onconova Therapeutics (ONTX)

Onconova Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ONTX
DateTimeSourceHeadlineSymbolCompany
02/09/20244:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
02/09/20244:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
02/08/20243:09PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
10/27/20233:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
10/27/20233:35PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
09/29/20234:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONTXOnconova Therapeutics Inc
08/15/20233:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONTXOnconova Therapeutics Inc
08/14/20234:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
08/14/20234:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
08/14/20234:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
08/14/20234:47PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
08/14/20234:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
08/14/20234:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
08/14/20234:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
08/14/20234:28PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ONTXOnconova Therapeutics Inc
08/10/20234:18PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONTXOnconova Therapeutics Inc
08/04/20233:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
08/04/20233:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
07/21/20233:50PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ONTXOnconova Therapeutics Inc
07/21/20233:45PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONTXOnconova Therapeutics Inc
07/11/202311:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ONTXOnconova Therapeutics Inc
06/30/20233:46PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ONTXOnconova Therapeutics Inc
06/13/20233:55PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONTXOnconova Therapeutics Inc
06/07/20233:31PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ONTXOnconova Therapeutics Inc
05/15/20234:29PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONTXOnconova Therapeutics Inc
05/09/20237:36AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONTXOnconova Therapeutics Inc
03/30/20233:47PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:ONTXOnconova Therapeutics Inc
03/14/20236:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONTXOnconova Therapeutics Inc
03/14/20235:49PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONTXOnconova Therapeutics Inc
03/14/20235:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONTXOnconova Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ONTX

Your Recent History

COIN
SHIBUSD
SHIBA INU
USOTC
HIRU
Hiru (PK)
USOTC
WDLF
Decentral Life (PK)
USOTC
DBMM
Digital Brand Media and ... (PK)
COIN
XRPUSD
Ripple
USOTC
NWBO
Northwest Biotherapeutics (QB)
NASDAQ
AMRN
Amarin
USOTC
RNVA
Rennova Health (CE)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
NBRI
North Bay Resources (PK)
USOTC
ASII
Accredited Solutions (PK)
NASDAQ
LWLG
Lightwave Logic
USOTC
CGAC
Code Green Apparel (PK)
USOTC
BIEL
Bioelectronics (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
FNMA
Fannie Mae (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for Canadian Securities Exchange (CSE) Level 1 and 2

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $738.72 only $295.49